FRO - Grant of synthetic options

27 May 2025 22:30 CEST

Frontline plc ("Frontline" or the "Company") hereby announces that 362,284
synthetic options have today been granted to management and employees of the
Company. The synthetic options will have a five-year term expiring May
27, 2030, and will vest over a three-year vesting period as follows:

* 1/3 of the synthetic options will vest on May 27, 2026
* 1/3 of the synthetic options will vest on May 27, 2027
* 1/3 of the synthetic options will vest on May 27, 2028

The  exercise price of the synthetic options  is USD 16.8 being the volume-
weighted average price of the share the last 30 days prior to grant. The
exercise price will further be adjusted for any distribution of dividends made
before the relevant synthetic options are exercised. The synthetic options
granted to the CEO and the CFO are subject to a cap on maximum annual gain equal
to two times the annual base salary at the time of exercise of the synthetic
options.

The synthetic options will be settled in cash based on the difference between
the market price of the Company's shares and the exercise price on the date of
exercise.

The synthetic options have been granted according to the rules of the Company's
synthetic option scheme approved by the Board of Directors of the Company.
Please see the attached forms of notification of transactions by primary
insiders for the synthetic options.

May 27, 2025

The Board of Directors
Frontline plc
Limassol, Cyprus

This notification has been publicly disclosed in accordance with Article 19 of
the Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading
Act.

More information:
Access the news on Oslo Bors NewsWeb site

647730_PDMR transactions.pdf